This discovery suggests that, in different types of cancers, the expression of PD-L1 relies on the presence of CMTM6, which is consistent with the previous report in cellular model that PD-L1 relies on CMTM6 to efficiently carry out its inhibitory functions [7]. This evidence concerns the gene CMTM6 and cancer.